Moderna receives FDA approval for first mRNA flu vaccine
7 outlets - including Investing, Yahoo and Inc and 4 more - are covering this story. The vaccine could give Moderna a foothold in seasonal flu and strengthen the case for mRNA shots against fast-changing diseases and cancer.
Covered by 7 outlets
All coverage · 10 articles
MRNA Stock Gets a Shot in the Arm as FDA Approves Moderna Flu Vaccine
Moderna’s First mRNA Flu Shot Just Won FDA Approval. Now Researchers See Potential for HIV and Malaria
The vaccine could give Moderna a foothold in seasonal flu and strengthen the case for mRNA shots against fast-changing diseases and cancer.
FDA approves Moderna’s mRNA flu vaccine
The clearance paves the way for the first preventive flu shot based on mRNA technology and completes a dramatic regulatory turnaround.
FDA Approves First mRNA Flu Vaccine For Older Adults
The approval of Moderna’s new flu vaccine comes months after the FDA faced backlash for refusing to review the shot.
FDA approves Moderna's mRNA flu vaccine after initial pushback
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.
Moderna wins U.S. FDA approval for first mRNA-based flu vaccine
Moderna wins U.S. FDA approval for first mRNA-based flu vaccine
Moderna wins U.S. FDA approval for first mRNA-based flu vaccine
F.D.A. Approves Moderna’s mRNA Flu Vaccine
The agency had initially refused to even review the application but reversed course after a public outcry.